APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhalation Sevoflurane Anaesthetic Agent

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Inhalation Sevoflurane Anaesthetic Agent Market Analysis and Forecast 2026-2032

2 January 2026195 pages

Choose your research edition.

Industry ResearchInhalation Sevoflurane Anaesthetic Agent Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhalation Sevoflurane Anaesthetic Agent Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Inhalation Sevoflurane Anaesthetic Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhalation Sevoflurane Anaesthetic Agent Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhalation Sevoflurane Anaesthetic Agent Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Inhalation Sevoflurane Anaesthetic Agent market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Inhalation Sevoflurane Anaesthetic Agent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Inhalation Sevoflurane Anaesthetic Agent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Inhalation Sevoflurane Anaesthetic Agent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Inhalation Sevoflurane Anaesthetic Agent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Inhalation Sevoflurane Anaesthetic Agent include Maruishi, Piramal, PT Novell Pharmaceutical, Viatris, AbbVie and Baxter, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Inhalation Sevoflurane Anaesthetic Agent, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Inhalation Sevoflurane Anaesthetic Agent, also provides the sales of main regions and countries. Of the upcoming market potential for Inhalation Sevoflurane Anaesthetic Agent, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Inhalation Sevoflurane Anaesthetic Agent sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Inhalation Sevoflurane Anaesthetic Agent market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Inhalation Sevoflurane Anaesthetic Agent sales, projected growth trends, production technology, application and end-user industry.

Inhalation Sevoflurane Anaesthetic Agent Segment by Company

Maruishi

Piramal

PT Novell Pharmaceutical

Viatris

AbbVie

Baxter

Inhalation Sevoflurane Anaesthetic Agent Segment by Type

250ml/Bottle

120ml/Bottle

Other

Inhalation Sevoflurane Anaesthetic Agent Segment by Application

Hospital

Clinics

Other

Inhalation Sevoflurane Anaesthetic Agent Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalation Sevoflurane Anaesthetic Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhalation Sevoflurane Anaesthetic Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalation Sevoflurane Anaesthetic Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Inhalation Sevoflurane Anaesthetic Agent in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Inhalation Sevoflurane Anaesthetic Agent manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Inhalation Sevoflurane Anaesthetic Agent sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 250ml/Bottle Major Manufacturers Table 3. 120ml/Bottle Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Clinics Major Manufacturers Table 8. Other Major Manufacturers Table 9. Inhalation Sevoflurane Anaesthetic Agent Industry Trends Table 10. Inhalation Sevoflurane Anaesthetic Agent Industry Drivers Table 11. Inhalation Sevoflurane Anaesthetic Agent Industry Opportunities and Challenges Table 12. Inhalation Sevoflurane Anaesthetic Agent Industry Restraints Table 13. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2021-2026) Table 17. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2027-2032) Table 18. Global Inhalation Sevoflurane Anaesthetic Agent Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2021-2026) & (K Units) Table 20. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2027-2032) & (K Units) Table 21. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2021-2026) Table 22. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2027-2032) Table 23. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Manufacturers (2021-2026) Table 27. Global Inhalation Sevoflurane Anaesthetic Agent Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Inhalation Sevoflurane Anaesthetic Agent Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Inhalation Sevoflurane Anaesthetic Agent Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Inhalation Sevoflurane Anaesthetic Agent Manufacturers, Product Type & Application Table 31. Global Inhalation Sevoflurane Anaesthetic Agent Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Inhalation Sevoflurane Anaesthetic Agent by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2021-2026) Table 38. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2027-2032) Table 39. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2026) & (K Units) Table 41. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2027-2032) & (K Units) Table 42. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2021-2026) Table 43. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2027-2032) Table 44. Global Inhalation Sevoflurane Anaesthetic Agent Price by Type (2021-2026) & (US$/Unit) Table 45. Global Inhalation Sevoflurane Anaesthetic Agent Price by Type (2027-2032) & (US$/Unit) Table 46. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2021-2026) Table 50. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2027-2032) Table 51. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2026) & (K Units) Table 53. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2027-2032) & (K Units) Table 54. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2021-2026) Table 55. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2027-2032) Table 56. Global Inhalation Sevoflurane Anaesthetic Agent Price by Application (2021-2026) & (US$/Unit) Table 57. Global Inhalation Sevoflurane Anaesthetic Agent Price by Application (2027-2032) & (US$/Unit) Table 58. Maruishi Company Information Table 59. Maruishi Business Overview Table 60. Maruishi Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Maruishi Inhalation Sevoflurane Anaesthetic Agent Product Portfolio Table 62. Maruishi Recent Development Table 63. Piramal Company Information Table 64. Piramal Business Overview Table 65. Piramal Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Piramal Inhalation Sevoflurane Anaesthetic Agent Product Portfolio Table 67. Piramal Recent Development Table 68. PT Novell Pharmaceutical Company Information Table 69. PT Novell Pharmaceutical Business Overview Table 70. PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Portfolio Table 72. PT Novell Pharmaceutical Recent Development Table 73. Viatris Company Information Table 74. Viatris Business Overview Table 75. Viatris Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Viatris Inhalation Sevoflurane Anaesthetic Agent Product Portfolio Table 77. Viatris Recent Development Table 78. AbbVie Company Information Table 79. AbbVie Business Overview Table 80. AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Portfolio Table 82. AbbVie Recent Development Table 83. Baxter Company Information Table 84. Baxter Business Overview Table 85. Baxter Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Baxter Inhalation Sevoflurane Anaesthetic Agent Product Portfolio Table 87. Baxter Recent Development Table 88. North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2021-2026) & (US$ Million) Table 89. North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2027-2032) & (US$ Million) Table 90. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2026) & (K Units) Table 91. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2027-2032) & (K Units) Table 92. North America Inhalation Sevoflurane Anaesthetic Agent Sales Price by Type (2021-2026) & (US$/Unit) Table 93. North America Inhalation Sevoflurane Anaesthetic Agent Sales Price by Type (2027-2032) & (US$/Unit) Table 94. North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2021-2026) & (US$ Million) Table 95. North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2027-2032) & (US$ Million) Table 96. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2026) & (K Units) Table 97. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2027-2032) & (K Units) Table 98. North America Inhalation Sevoflurane Anaesthetic Agent Sales Price by Application (2021-2026) & (US$/Unit) Table 99. North America Inhalation Sevoflurane Anaesthetic Agent Sales Price by Application (2027-2032) & (US$/Unit) Table 100. North America Inhalation Sevoflurane Anaesthetic Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Inhalation Sevoflurane Anaesthetic Agent Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 102. North America Inhalation Sevoflurane Anaesthetic Agent Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 103. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 104. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2026) & (K Units) Table 105. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2027-2032) & (K Units) Table 106. North America Inhalation Sevoflurane Anaesthetic Agent Sales Price by Country (2021-2026) & (US$/Unit) Table 107. North America Inhalation Sevoflurane Anaesthetic Agent Sales Price by Country (2027-2032) & (US$/Unit) Table 108. United States Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Table 109. Canada Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Table 110. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2021-2026) & (US$ Million) Table 111. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2027-2032) & (US$ Million) Table 112. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2026) & (K Units) Table 113. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2027-2032) & (K Units) Table 114. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Price by Type (2021-2026) & (US$/Unit) Table 115. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Price by Type (2027-2032) & (US$/Unit) Table 116. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2026) & (K Units) Table 119. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2027-2032) & (K Units) Table 120. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Price by Application (2021-2026) & (US$/Unit) Table 121. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Price by Application (2027-2032) & (US$/Unit) Table 122. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 124. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 125. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 126. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2026) & (K Units) Table 127. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2027-2032) & (K Units) Table 128. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Price by Country (2021-2026) & (US$/Unit) Table 129. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Price by Country (2027-2032) & (US$/Unit) Table 130. Germany Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Table 131. France Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Table 132. U.K. Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Table 133. Italy Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Table 134. Netherlands Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Table 135. China Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2021-2026) & (US$ Million) Table 136. China Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2027-2032) & (US$ Million) Table 137. China Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2026) & (K Units) Table 138. China Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2027-2032) & (K Units) Table 139. China Inhalation Sevoflurane Anaesthetic Agent Sales Price by Type (2021-2026) & (US$/Unit) Table 140. China Inhalation Sevoflurane Anaesthetic Agent Sales Price by Type (2027-2032) & (US$/Unit) Table 141. China Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2021-2026) & (US$ Million) Table 142. China Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2027-2032) & (US$ Million) Table 143. China Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2026) & (K Units) Table 144. China Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2027-2032) & (K Units) Table 145. China Inhalation Sevoflurane Anaesthetic Agent Sales Price by Application (2021-2026) & (US$/Unit) Table 146. China Inhalation Sevoflurane Anaesthetic Agent Sales Price by Application (2027-2032) & (US$/Unit) Table 147. Asia Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2026) & (K Units) Table 150. Asia Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2027-2032) & (K Units) Table 151. Asia Inhalation Sevoflurane Anaesthetic Agent Sales Price by Type (2021-2026) & (US$/Unit) Table 152. Asia Inhalation Sevoflurane Anaesthetic Agent Sales Price by Type (2027-2032) & (US$/Unit) Table 153. Asia Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2021-2026) & (US$ Million) Table 154. Asia Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2026) & (K Units) Table 156. Asia Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2027-2032) & (K Units) Table 157. Asia Inhalation Sevoflurane Anaesthetic Agent Sales Price by Application (2021-2026) & (US$/Unit) Table 158. Asia Inhalation Sevoflurane Anaesthetic Agent Sales Price by Application (2027-2032) & (US$/Unit) Table 159. Asia Inhalation Sevoflurane Anaesthetic Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia Inhalation Sevoflurane Anaesthetic Agent Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Asia Inhalation Sevoflurane Anaesthetic Agent Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Asia Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 163. Asia Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2026) & (K Units) Table 164. Asia Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2027-2032) & (K Units) Table 165. Asia Inhalation Sevoflurane Anaesthetic Agent Sales Price by Country (2021-2026) & (US$/Unit) Table 166. Asia Inhalation Sevoflurane Anaesthetic Agent Sales Price by Country (2027-2032) & (US$/Unit) Table 167. Japan Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Table 168. South Korea Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Table 169. India Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Table 170. Australia Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Table 171. China Taiwan Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Table 172. Southeast Asia Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Table 173. SAMEA Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2021-2026) & (US$ Million) Table 174. SAMEA Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2027-2032) & (US$ Million) Table 175. SAMEA Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2026) & (K Units) Table 176. SAMEA Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2027-2032) & (K Units) Table 177. SAMEA Inhalation Sevoflurane Anaesthetic Agent Sales Price by Type (2021-2026) & (US$/Unit) Table 178. SAMEA Inhalation Sevoflurane Anaesthetic Agent Sales Price by Type (2027-2032) & (US$/Unit) Table 179. SAMEA Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2021-2026) & (US$ Million) Table 180. SAMEA Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2027-2032) & (US$ Million) Table 181. SAMEA Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2026) & (K Units) Table 182. SAMEA Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2027-2032) & (K Units) Table 183. SAMEA Inhalation Sevoflurane Anaesthetic Agent Sales Price by Application (2021-2026) & (US$/Unit) Table 184. SAMEA Inhalation Sevoflurane Anaesthetic Agent Sales Price by Application (2027-2032) & (US$/Unit) Table 185. SAMEA Inhalation Sevoflurane Anaesthetic Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. SAMEA Inhalation Sevoflurane Anaesthetic Agent Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. SAMEA Inhalation Sevoflurane Anaesthetic Agent Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. SAMEA Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 189. SAMEA Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2026) & (K Units) Table 190. SAMEA Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2027-2032) & (K Units) Table 191. SAMEA Inhalation Sevoflurane Anaesthetic Agent Sales Price by Country (2021-2026) & (US$/Unit) Table 192. SAMEA Inhalation Sevoflurane Anaesthetic Agent Sales Price by Country (2027-2032) & (US$/Unit) Table 193. Brazil Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Table 194. Argentina Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Table 195. Chile Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Table 196. Colombia Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Table 197. Peru Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Table 198. Saudi Arabia Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Table 199. Israel Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Table 200. UAE Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Table 201. Turkey Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Table 202. Iran Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Table 203. Egypt Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. Inhalation Sevoflurane Anaesthetic Agent Distributors List Table 207. Inhalation Sevoflurane Anaesthetic Agent Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. Inhalation Sevoflurane Anaesthetic Agent Image Figure 2. Global Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhalation Sevoflurane Anaesthetic Agent Market Size Share 2021 VS 2025 VS 2032 Figure 4. 250ml/Bottle Image Figure 5. 120ml/Bottle Image Figure 6. Other Image Figure 7. Global Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Inhalation Sevoflurane Anaesthetic Agent Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinics Image Figure 11. Other Image Figure 12. Global Inhalation Sevoflurane Anaesthetic Agent Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Inhalation Sevoflurane Anaesthetic Agent Revenue (2021-2032) & (US$ Million) Figure 14. Global Inhalation Sevoflurane Anaesthetic Agent Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2021-2032) Figure 17. Global Inhalation Sevoflurane Anaesthetic Agent Sales (2021-2032) & (K Units) Figure 18. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Inhalation Sevoflurane Anaesthetic Agent Sales YoY (2021-2032) & (K Units) Figure 21. Europe Inhalation Sevoflurane Anaesthetic Agent Sales YoY (2021-2032) & (K Units) Figure 22. China Inhalation Sevoflurane Anaesthetic Agent Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Inhalation Sevoflurane Anaesthetic Agent Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales YoY (2021-2032) & (K Units) Figure 25. Global Inhalation Sevoflurane Anaesthetic Agent Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Inhalation Sevoflurane Anaesthetic Agent Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2021-2032) Figure 31. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2021-2032) Figure 34. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2021-2032) Figure 37. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2021-2032) Figure 40. North America Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Type (2021-2032) Figure 41. North America Inhalation Sevoflurane Anaesthetic Agent Sales Share by Type (2021-2032) Figure 42. North America Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Application (2021-2032) Figure 43. North America Inhalation Sevoflurane Anaesthetic Agent Sales Share by Application (2021-2032) Figure 44. North America Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Country (2021-2032) Figure 45. North America Inhalation Sevoflurane Anaesthetic Agent Sales Share by Country (2021-2032) Figure 46. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Type (2021-2032) Figure 47. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Share by Type (2021-2032) Figure 48. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Application (2021-2032) Figure 49. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Share by Application (2021-2032) Figure 50. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Country (2021-2032) Figure 51. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Share by Country (2021-2032) Figure 52. China Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Type (2021-2032) Figure 53. China Inhalation Sevoflurane Anaesthetic Agent Sales Share by Type (2021-2032) Figure 54. China Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Application (2021-2032) Figure 55. China Inhalation Sevoflurane Anaesthetic Agent Sales Share by Application (2021-2032) Figure 56. Asia Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Type (2021-2032) Figure 57. Asia Inhalation Sevoflurane Anaesthetic Agent Sales Share by Type (2021-2032) Figure 58. Asia Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Application (2021-2032) Figure 59. Asia Inhalation Sevoflurane Anaesthetic Agent Sales Share by Application (2021-2032) Figure 60. Asia Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Country (2021-2032) Figure 61. Asia Inhalation Sevoflurane Anaesthetic Agent Sales Share by Country (2021-2032) Figure 62. SAMEA Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Type (2021-2032) Figure 63. SAMEA Inhalation Sevoflurane Anaesthetic Agent Sales Share by Type (2021-2032) Figure 64. SAMEA Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Application (2021-2032) Figure 65. SAMEA Inhalation Sevoflurane Anaesthetic Agent Sales Share by Application (2021-2032) Figure 66. SAMEA Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Country (2021-2032) Figure 67. SAMEA Inhalation Sevoflurane Anaesthetic Agent Sales Share by Country (2021-2032) Figure 68. Inhalation Sevoflurane Anaesthetic Agent Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Inhalation Sevoflurane Anaesthetic Agent Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 250ml/Bottle
  • 120ml/Bottle
  • Other
Applications
  • Hospital
  • Clinics
  • Other
Companies covered
  • Maruishi
  • Piramal
  • PT Novell Pharmaceutical
  • Viatris
  • AbbVie
  • Baxter

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Inhalation Sevoflurane Anaesthetic Agent Market by Type
  3. 1.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 250ml/Bottle
  5. 1.2.3 120ml/Bottle
  6. 1.2.4 Other
  7. 1.3 Inhalation Sevoflurane Anaesthetic Agent Market by Application
  8. 1.3.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinics
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Inhalation Sevoflurane Anaesthetic Agent Market Dynamics
  1. 2.1 Inhalation Sevoflurane Anaesthetic Agent Industry Trends
  2. 2.2 Inhalation Sevoflurane Anaesthetic Agent Industry Drivers
  3. 2.3 Inhalation Sevoflurane Anaesthetic Agent Industry Opportunities and Challenges
  4. 2.4 Inhalation Sevoflurane Anaesthetic Agent Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region
  3. 3.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2021-2026)
  5. 3.2.3 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2027-2032)
  6. 3.2.4 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region
  9. 3.4.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2021-2026)
  11. 3.4.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2027-2032)
  12. 3.4.4 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Manufacturers
  2. 4.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Inhalation Sevoflurane Anaesthetic Agent Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Manufacturers
  6. 4.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Inhalation Sevoflurane Anaesthetic Agent Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Inhalation Sevoflurane Anaesthetic Agent Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Inhalation Sevoflurane Anaesthetic Agent Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Inhalation Sevoflurane Anaesthetic Agent Manufacturers, Product Type & Application
  13. 4.7 Global Inhalation Sevoflurane Anaesthetic Agent Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Inhalation Sevoflurane Anaesthetic Agent Market CR5 and HHI
  16. 4.8.2 2025 Inhalation Sevoflurane Anaesthetic Agent Tier 1, Tier 2, and Tier 3
5 Inhalation Sevoflurane Anaesthetic Agent Market by Type
  1. 5.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type
  2. 5.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type
  6. 5.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2021-2032)
  9. 5.3 Global Inhalation Sevoflurane Anaesthetic Agent Price by Type
6 Inhalation Sevoflurane Anaesthetic Agent Market by Application
  1. 6.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application
  2. 6.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application
  6. 6.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2021-2032)
  9. 6.3 Global Inhalation Sevoflurane Anaesthetic Agent Price by Application
7 Company Profiles
  1. 7.1 Maruishi
  2. 7.1.1 Maruishi Company Information
  3. 7.1.2 Maruishi Business Overview
  4. 7.1.3 Maruishi Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Maruishi Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
  6. 7.1.5 Maruishi Recent Developments
  7. 7.2 Piramal
  8. 7.2.1 Piramal Company Information
  9. 7.2.2 Piramal Business Overview
  10. 7.2.3 Piramal Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Piramal Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
  12. 7.2.5 Piramal Recent Developments
  13. 7.3 PT Novell Pharmaceutical
  14. 7.3.1 PT Novell Pharmaceutical Company Information
  15. 7.3.2 PT Novell Pharmaceutical Business Overview
  16. 7.3.3 PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 PT Novell Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
  18. 7.3.5 PT Novell Pharmaceutical Recent Developments
  19. 7.4 Viatris
  20. 7.4.1 Viatris Company Information
  21. 7.4.2 Viatris Business Overview
  22. 7.4.3 Viatris Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Viatris Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
  24. 7.4.5 Viatris Recent Developments
  25. 7.5 AbbVie
  26. 7.5.1 AbbVie Company Information
  27. 7.5.2 AbbVie Business Overview
  28. 7.5.3 AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
  30. 7.5.5 AbbVie Recent Developments
  31. 7.6 Baxter
  32. 7.6.1 Baxter Company Information
  33. 7.6.2 Baxter Business Overview
  34. 7.6.3 Baxter Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Baxter Inhalation Sevoflurane Anaesthetic Agent Product Portfolio
  36. 7.6.5 Baxter Recent Developments
8 North America
  1. 8.1 North America Inhalation Sevoflurane Anaesthetic Agent Market Size by Type
  2. 8.1.1 North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2021-2032)
  3. 8.1.2 North America Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2032)
  4. 8.1.3 North America Inhalation Sevoflurane Anaesthetic Agent Price by Type (2021-2032)
  5. 8.2 North America Inhalation Sevoflurane Anaesthetic Agent Market Size by Application
  6. 8.2.1 North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2021-2032)
  7. 8.2.2 North America Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2032)
  8. 8.2.3 North America Inhalation Sevoflurane Anaesthetic Agent Price by Application (2021-2032)
  9. 8.3 North America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country
  10. 8.3.1 North America Inhalation Sevoflurane Anaesthetic Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Inhalation Sevoflurane Anaesthetic Agent Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Inhalation Sevoflurane Anaesthetic Agent Market Size by Type
  2. 9.1.1 Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2021-2032)
  3. 9.1.2 Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2032)
  4. 9.1.3 Europe Inhalation Sevoflurane Anaesthetic Agent Price by Type (2021-2032)
  5. 9.2 Europe Inhalation Sevoflurane Anaesthetic Agent Market Size by Application
  6. 9.2.1 Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2021-2032)
  7. 9.2.2 Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2032)
  8. 9.2.3 Europe Inhalation Sevoflurane Anaesthetic Agent Price by Application (2021-2032)
  9. 9.3 Europe Inhalation Sevoflurane Anaesthetic Agent Market Size by Country
  10. 9.3.1 Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Inhalation Sevoflurane Anaesthetic Agent Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Inhalation Sevoflurane Anaesthetic Agent Market Size by Type
  2. 10.1.1 China Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2021-2032)
  3. 10.1.2 China Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2032)
  4. 10.1.3 China Inhalation Sevoflurane Anaesthetic Agent Price by Type (2021-2032)
  5. 10.2 China Inhalation Sevoflurane Anaesthetic Agent Market Size by Application
  6. 10.2.1 China Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2021-2032)
  7. 10.2.2 China Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2032)
  8. 10.2.3 China Inhalation Sevoflurane Anaesthetic Agent Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Inhalation Sevoflurane Anaesthetic Agent Market Size by Type
  2. 11.1.1 Asia Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2021-2032)
  3. 11.1.2 Asia Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2032)
  4. 11.1.3 Asia Inhalation Sevoflurane Anaesthetic Agent Price by Type (2021-2032)
  5. 11.2 Asia Inhalation Sevoflurane Anaesthetic Agent Market Size by Application
  6. 11.2.1 Asia Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2021-2032)
  7. 11.2.2 Asia Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2032)
  8. 11.2.3 Asia Inhalation Sevoflurane Anaesthetic Agent Price by Application (2021-2032)
  9. 11.3 Asia Inhalation Sevoflurane Anaesthetic Agent Market Size by Country
  10. 11.3.1 Asia Inhalation Sevoflurane Anaesthetic Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Inhalation Sevoflurane Anaesthetic Agent Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Inhalation Sevoflurane Anaesthetic Agent Market Size by Type
  2. 12.1.1 SAMEA Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Inhalation Sevoflurane Anaesthetic Agent Price by Type (2021-2032)
  5. 12.2 SAMEA Inhalation Sevoflurane Anaesthetic Agent Market Size by Application
  6. 12.2.1 SAMEA Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Inhalation Sevoflurane Anaesthetic Agent Price by Application (2021-2032)
  9. 12.3 SAMEA Inhalation Sevoflurane Anaesthetic Agent Market Size by Country
  10. 12.3.1 SAMEA Inhalation Sevoflurane Anaesthetic Agent Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Inhalation Sevoflurane Anaesthetic Agent Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Inhalation Sevoflurane Anaesthetic Agent Value Chain Analysis
  2. 13.1.1 Inhalation Sevoflurane Anaesthetic Agent Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Inhalation Sevoflurane Anaesthetic Agent Production Mode & Process
  6. 13.2 Inhalation Sevoflurane Anaesthetic Agent Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Inhalation Sevoflurane Anaesthetic Agent Distributors
  9. 13.2.3 Inhalation Sevoflurane Anaesthetic Agent Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst